Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Aug, 21 2025
Mar, 16 2026
Aug, 20 2026
Dec, 26 2025
Oct, 11 2025